Trials / Recruiting
RecruitingNCT06658353
Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
Single-arm, Open, Multi-center Phase III Clinical Study to Assess the Safety and Effectiveness of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This Study is a single arm, open label, multicenter phase III clinical trial to evaluate the safety and efficacy of VC004 in patients with locally advanced/metastatic solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VC004 Capsules | VC004 Capsules BID |
Timeline
- Start date
- 2025-03-17
- Primary completion
- 2026-12-30
- Completion
- 2026-12-30
- First posted
- 2024-10-26
- Last updated
- 2025-03-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06658353. Inclusion in this directory is not an endorsement.